Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sen Wan

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
International Journal of Surgery (London, England)|April 23, 2024
Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trialRong-Xin Zhang, Xiao-Jun Wu, De-Sen Wan, et al.
Plos Medicine|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trialDe-Shen Wang, Chao Ren, Shan-Shan Li, et al.
Annals of Surgery|November 3, 2025
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational StudyDi Cao, Guang-Zhao Lv, Cong Li, et al.
International Journal of Cancer|December 7, 2018
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular featuresWu Jiang, Mu-Yan Cai, Shi-Yong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III TrialWei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang, et al.
Annals of Surgery|December 20, 2022
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III TrialWei-Jian Mei, Xiao-Zhong Wang, Yun-Feng Li, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
International Journal of Surgery (London, England)|April 23, 2024
Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trialRong-Xin Zhang, Xiao-Jun Wu, De-Sen Wan, et al.
Plos Medicine|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trialDe-Shen Wang, Chao Ren, Shan-Shan Li, et al.
Annals of Surgery|November 3, 2025
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational StudyDi Cao, Guang-Zhao Lv, Cong Li, et al.
International Journal of Cancer|December 7, 2018
Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular featuresWu Jiang, Mu-Yan Cai, Shi-Yong Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III TrialWei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang, et al.
Annals of Surgery|December 20, 2022
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III TrialWei-Jian Mei, Xiao-Zhong Wang, Yun-Feng Li, et al.
Pageof 13